Samyang Biopharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Samyang Biopharmaceuticals Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013492
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Samyang Biopharmaceuticals Corp (Samyang Biopharm) researches and develops technology platforms for drug delivery. Its product portfolio comprises transdermal patches, injections, ORC hemostat and others. The company spans its expertise in the development and distribution of biodegradable, synthetic absorbable suture materials, biodegradable dental implant (GTR, GBR) membrane and partially absorbable lightweight Hernia Mesh and single-use absorbable endoscopic loop. Samyang Biopharm also provides active pharmaceutical ingredients (APIs) utilizing novel plant cell culture and semisynthetic technologies. It offers its products for the treatment of breast, lung, ovarian, head and neck cancer, and pneumonia of colitis among others. The company through its subsidiaries collaborates with biotechnology, pharmaceutical, venture firms, research institutes and universities to develop new products and technologies. Samyang Biopharm is headquartered in Gyeonggi-do, South Korea.

Samyang Biopharmaceuticals Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Samyang Biopharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Samyang Biopharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Samyang Biopharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Samyang Biopharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Samyang Biopharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Samyang Biopharmaceuticals Corp, Pharmaceuticals & Healthcare, Deal Details 10
Asset Transactions 10
Sorrento Therapeutics Acquires Rights to Cynviloq from Samyang Biopharma 10
Sorrento Therapeutics Acquires Rights To Cynviloq From Samyang Biopharma 11
Sorrento Therapeutics And IgDraSol Acquire Distribution Rights Of Cynviloq From Samyang Biopharma 12
Samyang Biopharmaceuticals Corp – Key Competitors 13
Samyang Biopharmaceuticals Corp – Key Employees 14
Samyang Biopharmaceuticals Corp – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Samyang Biopharmaceuticals Corp, Pharmaceuticals & Healthcare, Key Facts 2
Samyang Biopharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Samyang Biopharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Samyang Biopharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Samyang Biopharmaceuticals Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Samyang Biopharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sorrento Therapeutics Acquires Rights to Cynviloq from Samyang Biopharma 10
Sorrento Therapeutics Acquires Rights To Cynviloq From Samyang Biopharma 11
Sorrento Therapeutics And IgDraSol Acquire Distribution Rights Of Cynviloq From Samyang Biopharma 12
Samyang Biopharmaceuticals Corp, Key Competitors 13
Samyang Biopharmaceuticals Corp, Key Employees 14

★海外企業調査レポート[Samyang Biopharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NeoGenomics Inc (NEO)-医療機器分野:企業M&A・提携分析
    Summary NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immuno …
  • Ornim Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ornim Inc (Ornim) is a medical device company that specializes in clinical research, development and distribution of medical devices in the field of tissue and cerebral blood flow and perfusion, among others. The company’s c-FLOW is a continuous non-invasive monitor of deep tissue blood flow …
  • Buck Institute for Research on Aging:製薬・医療:M&Aディール及び事業提携情報
    Summary Buck Institute for Research on Aging (Buck Institute) is a biomedical institute that conducts research on aging and chronic disease. The institute concentrates on understanding the connection between aging and chronic disease. It carries out research and develops treatments in the therapeuti …
  • Bonanza Creek Energy Inc (BCEI):石油・ガス:M&Aディール及び事業提携情報
    Summary Bonanza Creek Energy Inc (Bonanza Creek) is an oil and gas company that acquires, explores, develops and produces onshore oil and liquid-rich natural gas assets. The company employs hydraulic fracturing for oil and natural gas exploration, and measurement while drilling technology or borehol …
  • R. R. Donnelley & Sons Company:企業の戦略・SWOT・財務情報
    R. R. Donnelley & Sons Company - Strategy, SWOT and Corporate Finance Report Summary R. R. Donnelley & Sons Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Radius Health Inc (RDUS):企業の財務・戦略的SWOT分析
    Radius Health Inc (RDUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Alnylam Pharmaceuticals Inc (ALNY)-医療機器分野:企業M&A・提携分析
    Summary Alnylam Pharmaceuticals Inc, (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines; cardiova …
  • SS&C Technologies Holdings Inc.:企業のM&A・事業提携・投資動向
    SS&C Technologies Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SS&C Technologies Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Southern California Edison Co:企業の発電所・SWOT分析2018
    Southern California Edison Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Patterson-UTI Energy Inc (PTEN):企業の財務・戦略的SWOT分析
    Patterson-UTI Energy Inc (PTEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Komatsu Ltd (6301):企業の財務・戦略的SWOT分析
    Komatsu Ltd (6301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Equipos Nucleares SA:企業の戦略的SWOT分析
    Equipos Nucleares SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Hovnanian Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Hovnanian Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hovnanian Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Redrow Plc:企業の戦略・SWOT・財務情報
    Redrow Plc - Strategy, SWOT and Corporate Finance Report Summary Redrow Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Massachusetts Eye and Ear Infirmary-製薬・医療分野:企業M&A・提携分析
    Summary Massachusetts Eye and Ear Infirmary (MEE) is a healthcare service provider that offers primary, medical and surgical care services. The hospital offers services through departments such as ophthalmology, otolaryngology and patient care services. Its patient care services include patient educ …
  • Theranostics Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Theranostics Health Inc (Theranostics), a subsidiary of Avant Diagnostics Inc is a healthcare service provider that offers protein based solutions. The company provides protein based discovery and translational research services. Its products include molecular navigation of targeted therapie …
  • Honeywell International Inc (HON):電力:M&Aディール及び事業提携情報
    Summary Honeywell International Inc. (Honeywell) is a diversified manufacturing and technology company. The company offers avionics, aircraft engines, systems and service solutions; environmental and combustion controls, sensing controls, security and life safety products and services, scanning and …
  • DiaMedica Therapeutics Inc (DMA):企業の財務・戦略的SWOT分析
    Summary DiaMedica Therapeutics Inc (DiaMedica) formerly DiaMedica Inc, is a clinical-stage bio pharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 …
  • Welltec AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Welltec AS (Welltec) is an oil and gas service provider that develops and offers well technologies and solutions for the oil and gas industries. The company's solutions include wireline services, milling solutions, robotic well solutions, conveyance solutions, clean-out solutions, and mechan …
  • Ctrip.com International, Ltd.:企業の戦略・SWOT・財務情報
    Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆